# Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers

> **NCT03134027** · — · TERMINATED · sponsor: **Duke University** · enrollment: 3 (actual)

## Conditions studied

- Genito Urinary Cancer
- Bladder Cancer
- Kidney Cancer
- Prostate Cancer

## Interventions

- **PROCEDURE:** Bone marrow biopsy
- **PROCEDURE:** Tumor biopsy

## Key facts

- **NCT ID:** NCT03134027
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-19
- **Primary completion:** 2018-05-09
- **Final completion:** 2018-05-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2024-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134027, "Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03134027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*